Haemophilus type b and meningococcal group C conjugate vaccine : List of nationally authorised medicinal products - PSUSA/00001583/202302

Influenza vaccine (surface antigen, inactivated) : List of nationally authorised medicinal products - PSUSA/00001744/202303

Opinion/decision on a Paediatric investigation plan (PIP): Ex vivo expanded autologous human keratinocytes containing epidermal stem cells genetically modified with a gamma-retroviral (RV) vector expressing the full-length LAMB3 cDNA (Hologene 5), decision type: , therapeutic area: , PIP number: P/0375/2022

Opinion/decision on a Paediatric investigation plan (PIP): Ibrexafungerp citrate, decision type: , therapeutic area: , PIP number: P/0370/2022

Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli,Pegcetacoplan, decision type: , therapeutic area: , PIP number: P/0403/2022

Opinion/decision on a Paediatric investigation plan (PIP): Clazakizumab, decision type: , therapeutic area: , PIP number: P/0393/2022

Fenoterol / ipratropium : List of nationally authorised medicinal products - PSUSA/00001367/202302

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Hepatitis D, Chronic, Date of authorisation: 31/07/2020, Revision: 11, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Momelotinib, decision type: , therapeutic area: , PIP number: P/0157/2015

Opinion/decision on a Paediatric investigation plan (PIP): Momelotinib, decision type: , therapeutic area: , PIP number: P/0249/2019